Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar:314:122864.
doi: 10.1016/j.biomaterials.2024.122864. Epub 2024 Sep 28.

Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction

Affiliations

Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction

Georgios Pavlou et al. Biomaterials. 2025 Mar.

Abstract

The blood-brain barrier (BBB) serves as a selective filter that prevents harmful substances from entering the healthy brain. Dysfunction of this barrier is implicated in several neurological diseases. In the context of Alzheimer's disease (AD), BBB breakdown plays a significant role in both the initiation and progression of the disease. This study introduces a three-dimensional (3D) self-assembled in vitro model of the human neurovascular unit to recapitulate some of the complex interactions between the BBB and AD pathologies. It incorporates primary human brain endothelial cells, pericytes and astrocytes, and stem cell-derived neurons and astrocytes harboring Familial AD (FAD) mutations. Over an extended co-culture period, the model demonstrates increased BBB permeability, dysregulation of key endothelial and pericyte markers, and morphological alterations mirroring AD pathologies. The model enables visualization of amyloid-beta (Aβ) accumulation in both neuronal and vascular compartments. This model may serve as a versatile tool for neuroscience research and drug development to provide insights into the dynamic relationship between vascular dysfunction and AD pathogenesis.

Keywords: Alzheimer's disease; Amyloid-β; Blood-brain barrier; Neurovascular unit; Perfusable 3D brain in vitro model.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest R.D.K. is a co-founder of AIM Biotech, a company that markets microfluidic technologies and receives research support from Amgen, Abbvie, Boehringer-Ingelheim, Daiichi-Sankyo, Novartis, Roche, Takeda, Eisai, EMD Serono, and Visterra.

References

    1. Knopman DD, et al., Alzheimer’s disease, Nat Rev Dis Primers 7 (2021) 1–21. - PMC - PubMed
    1. Hebert LE, Weuve J, Scherr PA, Evans DA, Alzheimer disease in the United States (2010–2050) estimated using the 2010 census, Neurology 80 (2013) 1778–1783. - PMC - PubMed
    1. Tanzi RE, Bertram L, Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective, Cell 120 (2005) 545–555. - PubMed
    1. Goedert M, Spillantini MG, A century of Alzheimer’s disease, Science 314 (2006) 777–781. - PubMed
    1. Hanseeuw BJ, et al., Association of amyloid and tau with cognition in preclinical alzheimer disease: a longitudinal study, JAMA Neurol. 76 (2019) 915–924. - PMC - PubMed

Substances

LinkOut - more resources